Matilde López

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Centro de Ingeniería Genética y Biotecnología(Current)

Matilde López is an author at Centro de Ingeniería Genética y Biotecnología specializing in pharmacology, peripheral t cell tolerance, and biochemistry.

Publications per year

2011–2023

Publications

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

Silvio E. Perea, Idania Baladrón, Yanelda García et al. · Molecular and Cellular Biochemistry · 2011 · 43 citations

Life Sciences, Biochemistry, Pharmacology +9

Phase I Clinical Trial with a Novel Altered Peptide Ligand Derived from Human Heat-Shock Protein 60 for Treatment of Rheumatoid Arthritis: Safety, Pharmacokinetics and Preliminary Therapeutic Effects

Dinorah Prada, Jorge A. Gómez, Norailys Lorenzo et al. · Journal of Clinical Trials · 2018 · 15 citations

Medicine, Pharmacokinetics, Pharmacology +17

Characterization of the size distribution and aggregation of virus-like nanoparticles used as active ingredients of the HeberNasvac therapeutic vaccine against chronic hepatitis B

Matilde López, E.N. Rodríguez, Yadira Lobaina et al. · Advances in Natural Sciences Nanoscience and Nanotechnology · 2017 · 10 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Alginate Microsponges as a Scaffold for Delivery of a Therapeutic Peptide against Rheumatoid Arthritis

Daniela Ariaudo, Francesca Cavalieri, Antonio Rinaldi et al. · Nanomaterials · 2023 · 10 citations · Full text

Pharmacy, Biomedical Engineering, Pharmaceutics +17

1–4 of 4